Autism Spectrum Disorder Trial, Recruiting NCT06927518 Sponsor: Riphah International University Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT06927518
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The child is between 3 and 5 years old and has been diagnosed with Autism Spectrum Disorder (ASD).
  • The child is able to attend therapy sessions regularly as required by the study, whether in a group or one-on-one setting.
  • Both boys and girls are welcome to participate.

Who may not be able to join:

  • Children who have another serious medical condition alongside their ASD diagnosis.
  • Children who have already received intensive speech and language therapy focused on understanding language (receptive language skills) within the past 6 months.
  • Children whose behavioral challenges, such as aggression or extreme hyperactivity, are severe enough that they may struggle to participate in group or individual therapy sessions.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Syeda Mariam Zahra, MS SLP, Riphah International University

Phone: 03324390125

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
20 March 2025
Est. completion
20 June 2025

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Laura Mize Teach Me To Talk receptive language checklist, Me To Talk receptive language checklist,

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov